Fifty years ago, the United States had 75 car companies. Today, there are fewer than five. The same consolidation dynamics are reshaping physician practice management, says Ezra Simons, a co-founder and partner at Physician Growth Partners, which has
Continue Reading The Era of Physician Practice Consolidation, With Ezra Simons
Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Sells MaxHealth to CenterWell
Arsenal Capital has sold MaxHealth to CenterWell, according to a news release.
MaxHealth, founded in 2015 and based in Tampa, Florida, is a network of primary care facilities for adults and seniors with over 50 locations throughout Florida.
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Arsenal Sells MaxHealth to CenterWellNew Exit Opportunities in Provider Services M&A, With Michael Kroin
From his perspective as CEO and managing partner at Physician Growth Partners, Michael Kroin sees an “interesting time” where different types of buyers are getting into the provider services sector at the same time that payers are aggressively pursuing
Continue Reading New Exit Opportunities in Provider Services M&A, With Michael KroinHealthcare & Life Sciences Private Equity Deal Tracker: J.P. Morgan Life Sciences Invests in Turbett Surgical
J.P. Morgan Life Sciences Private Capital has invested in Turbett Surgical, according to a news release.
Turbett, founded in 2013 and based in Henrietta, New York, is a medical equipment company that manufactures mobile sterilization pods and consumable
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: J.P. Morgan Life Sciences Invests in Turbett SurgicalHealthcare & Life Sciences Private Equity Deal Tracker: Lead Capital Invests in PedsOne
Lead Capital Partners (LCP) has announced an investment in PedsOne.
PedsOne, founded in 2011 and based in Nashville, Tennessee, is a provider of outsourced revenue cycle management and consulting services to independent pediatric practices throughout the United States.
Continue Reading Healthcare & Life Sciences Private Equity Deal Tracker: Lead Capital Invests in PedsOneLindsay Goldberg Closes New Fund With $4.9 Billion
Lindsay Goldberg announced the closing of its sixth fund.
The fund, Lindsay Goldberg VI, closed with $4.9 billion, surpassing its target of $4.0 billion.
Lindsay Goldberg, founded in 2001 and based in New York, is a private investment firm
Continue Reading Lindsay Goldberg Closes New Fund With $4.9 BillionRivalry Capital Launches as Private Equity Firm Focusing on Healthcare
Rivalry Capital recently announced its launch.
Rivalry, based in Denver, is a private equity firm focused on investing in emerging and lower middle market companies in the healthcare and technology sectors.
The firm was founded by Jim Chandler, Matt
Continue Reading Rivalry Capital Launches as Private Equity Firm Focusing on HealthcareOpportunities in Lower Middle-Market Healthcare, With Ben Mackay
Lower middle-market private equity in government-reimbursed healthcare requires a different playbook — one that balances controlling ownership with founder retention to build long-term value. Evolve Capital has become a subject matter expert in the Medicare-reimbursed home healthcare space, and
Continue Reading Opportunities in Lower Middle-Market Healthcare, With Ben MackayWomen’s Health as Clinical and Economical Imperatives, With Priya Bathija
As founder and CEO of Nyoo Health, Priya Bathija encourages healthcare leaders to ask questions, starting with, “How does this impact women differently?” Nyoo Health helps leaders align, inspire and execute initiatives that strengthen women’s health services and position
Continue Reading Women’s Health as Clinical and Economical Imperatives, With Priya BathijaWhat’s Next in the Psychedelics Market, With Matt Brockmeier and Rebecca Nicholson
A range of new mental health treatments are available to Western medicine, and practitioners are figuring out how to use them effectively. Matt Brockmeier, co-founder and chief legal officer at Entheogyn and of counsel at Antithesis Law, joins
Continue Reading What’s Next in the Psychedelics Market, With Matt Brockmeier and Rebecca Nicholson